Abstract
Nuclear magnetic resonance (NMR) spectroscopy has been widely applied to many facets of cancer research. As the name implies, NMR spectroscopy is a technique that utilizes transitions between different states of a nucleus when placed in a magnetic field. NMR has been used for decades to identify and quantify the reactants and products associated with chemical reactions. More recently, it has been used in the field termed metabolomics to identify and quantify the small molecules of complex mixtures and how that molecular repertoire varies under various perturbations to the system being studied. NMR is also used for de novo three-dimensional structure determination of macromolecules including proteins and protein domains as well as to quantify the motions inherent in structures. A great strength of the technique is to characterize the interactions of small molecules with these macromolecules, which can be used for inhibitor discovery and development. These applications have direct relevance to cancer research and are described in this review.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akke M (2002) NMR methods for characterizing microsecond to millisecond dynamics in recognition and catalysis. Curr Opin Struct Biol 12(5):642–647
Baleja JD, Cherry JJ, Liu Z, Gao H, Nicklaus MC, Voigt JH et al (2006) Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins. Antivir Res 72:49–59
Be X, Hong Y, Wei J, Androphy EJ, Chen JJ, Baleja JD (2001) Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP. Biochemistry 40(5):1293–1299
Bingol K, Bruschweiler R (2015) Two elephants in the room: new hybrid nuclear magnetic resonance and mass spectrometry approaches for metabolomics. Curr Opin Clin Nutr Metab Care 18(5):471–477
Bogerd HP, Fridell RA, Madore S, Cullen BR (1995) Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82(3):485–494
Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120(3):303–313
Bose K, Yoder NC, Kumar K, Baleja JD (2007) The role of conserved histidines in the structure and stability of human papillomavirus type 16 E2 DNA-binding domain. Biochemistry 46(5):1402–1411
Bose K, Meinke G, Bohm A, Baleja JD (2011) Design and characterization of an enhanced repressor of human papillomavirus E2 protein. FASEB J 25:2354–2361
Brindle K (2012) Watching tumours gasp and die with MRI: the promise of hyperpolarised 13C MR spectroscopic imaging. Br J Radiol 85(1014):697–708
Bruntz RC, Lane AN, Higashi RM, Fan TW (2017) Exploring cancer metabolism using stable isotope resolved metabolomics (SIRM). J Biol Chem 292(28):11601–11609
Cheng RKY, Fiez-Vandal C, Schlenker O, Edman K, Aggeler B, Brown DG et al (2017) Structural insight into allosteric modulation of protease-activated receptor 2. Nature 545(7652):112–115
Cherry JJ, Rietz A, Malinkevich A, Liu Y, Xie M, Bartolowits M et al (2013) Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function. PLoS One 8(12):e84506
Chi CN, Bach A, Engstrom A, Stromgaard K, Lundstrom P, Ferguson N et al (2011) Biophysical characterization of the complex between human papillomavirus E6 protein and synapse-associated protein 97. J Biol Chem 286(5):3597–3606
Choi JS, Baek HM, Kim S, Kim MJ, Youk JH, Moon HJ et al (2012) HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors. PLoS One 7(12):e51712
Cisowski J, O'Callaghan K, Kuliopulos A, Yang J, Nguyen N, Deng Q et al (2011) Targeting protease-activated receptor-1 with cell-penetrating peducins in lung cancer. Am J Pathol 179:513–523
Comment A, Merritt ME (2014) Hyperpolarized magnetic resonance as a sensitive detector of metabolic function. Biochemistry 53(47):7333–7357
Confalonieri S, Di Fiore PP (2002) The Eps15 homology (EH) domain. FEBS Lett 513(1):24–29
Covic L, Gresser AL, Talavera J, Swift S, Kuliopulos A (2002a) Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides. Proc Natl Acad Sci USA 99(2):643–648
Covic L, Misra M, Badar J, Singh C, Kuliopulos A (2002b) Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation. Nat Med 8(10):1161–1165
Dias DM, Ciulli A (2014) NMR approaches in structure-based lead discovery: recent developments and new frontiers for targeting multi-protein complexes. Prog Biophys Mol Biol 116(2-3):101–112
Eisenmesser EZ, Millet O, Labeikovsky W, Korzhnev DM, Wolf-Watz M, Bosco DA et al (2005) Intrinsic dynamics of an enzyme underlies catalysis. Nature 438(7064):117–121
El-Sayed S, Bezabeh T, Odlum O, Patel R, Ahing S, MacDonald K et al (2002) An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head Neck 24(8):766–772
Englander SW, Downer NW, Teitelbaum H (1972) Hydrogen exchange. Annu Rev Biochem 41:903–924
Freedman SJ, Furie BC, Furie B, Baleja JD (1995) Structure of the calcium ion-bound γ-carboxyglutamic acid-rich domain of factor IX. Biochemistry 34:12126–12137
Fritz CC, Zapp ML, Green MR (1995) A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature 376(6540):530–533
Gentry LR, Martin TD, Reiner DJ, Der CJ (2014) Ral small GTPase signaling and oncogenesis: more than just 15 minutes of fame. Biochim Biophys Acta 1843(12):2976–2988
Gurbel PA, Bliden KP, Turner SE, Tantry US, Gesheff MG, Barr TP et al (2016) Cell-penetrating pepducin therapy targeting PAR1 in subjects with coronary artery disease. Arterioscler Thromb Vasc Biol 36(1):189–197
Hajduk PJ (2006) SAR by NMR: putting the pieces together. Mol Interv 6(5):266–272
Hajduk PJ, Gerfin T, Boehlen JM, Häberli M, Marek D, Fesik SW (1999) High-throughput nuclear magnetic resonance-based screening. J Med Chem 42(13):2315–2317
Hill JM, Roberts J, Loeb E, Khan A, MacLellan A, Hill RW (1967) L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. JAMA 202(9):882–888
Hyberts SG, Goldberg MS, Havel TF, Wagner G (1992) The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X-ray structures. Protein Sci 1:736–751
Ishima R, Torchia DA (2000) Protein dynamics from NMR. Nat Struct Biol 7(9):740–743
Janz JM, Ren Y, Looby R, Kazmi MA, Sachdev P, Grunbeck A et al (2011) Direct interaction between an allosteric agonist pepducin and the chemokine receptor CXCR4. J Am Chem Soc 133(40):15878–15881
Jeschke G, Frydman L (2016) Nuclear hyperpolarization comes of age. J Magn Reson 264:1–2
Johnson CH, Patterson AD, Krausz KW, Kalinich JF, Tyburski JB, Kang DW et al (2012) Radiation metabolomics. 5. Identification of urinary biomarkers of ionizing radiation exposure in nonhuman primates by mass spectrometry-based metabolomics. Radiat Res 178(4):328–340
Kaneider NC, Agarwal A, Leger AJ, Kuliopulos A (2005) Reversing systemic inflammatory response syndrome with chemokine receptor pepducins. Nat Med 11(6):661–665
Kaneider NC, Leger AJ, Agarwal A, Nguyen N, Perides G, Derian C et al (2007) ‘Role reversal’ for the receptor PAR1 in sepsis-induced vascular damage. Nat Immunol 8(12):1303–1312
Kay LE (2005) NMR studies of protein structure and dynamics. J Magn Reson 173(2):193–207
Kern D, Zuiderweg ER (2003) The role of dynamics in allosteric regulation. Curr Opin Struct Biol 13(6):748–757
Kim S, Dubelman AM, Goonesekera S, Feig LA, Baleja JD (2000) 1H, 15N, and 13C NMR resonance assignments for the Eps15 homology domain of Reps1. J Biomol NMR 18:367–368
Kim S, Cullis DN, Feig LA, Baleja JD (2001) Solution structure of the Reps1 EH domain and characterization of its binding to NPF target sequences. Biochemistry 40:6776–6785
Kind T, Tolstikov V, Fiehn O, Weiss RH (2007) A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem 363(2):185–195
Kuliopulos A, Covic L (2003) Blocking receptors on the inside: pepducin-based intervention of PAR signaling and thrombosis. Life Sci 74(2-3):255–262
Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8(4):477–486
Leger AJ, Covic L, Kuliopulos A (2006) Protease-activated receptors in cardiovascular diseases. Circulation 114(10):1070–1077
Li M, Song Y, Cho N, Chang JM, Koo HR, Yi A et al (2011) An HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsy. PLoS One 6(10):e25563
Liang H, Petros AM, Meadows RP, Yoon HSY, Egan DA, Walter K et al (1996) Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions. Biochemistry 35:2095–2103
Lin G, Keshari KR, Park JM (2017) Cancer metabolism and tumor heterogeneity: imaging perspectives using MR imaging and spectroscopy. Contrast Media Mol Imaging 2017:6053879
Liu Y, Liu Z, Androphy E, Chen J, Baleja JD (2004) Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus. Biochemistry 43(23):7421–7431
Liu Y, Henry GD, Hegde RS, Baleja JD (2007) Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein. Biochemistry 46(38):10864–10874
Liu Y, Cherry JJ, Dineen JV, Androphy EJ, Baleja JD (2009) Determinants of stability for the E6 protein of papillomavirus type 16. J Mol Biol 386(4):1123–1137
Louis E, Adriaensens P, Guedens W, Vanhove K, Vandeurzen K, Darquennes K et al (2016) Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types? Ann Oncol 27(1):178–184
Ludwig C, Ward DG, Martin A, Viant MR, Ismail T, Johnson PJ et al (2009) Fast targeted multidimensional NMR metabolomics of colorectal cancer. Magn Reson Chem 47(Suppl 1):S68–S73
Lussey-Lepoutre C, Hollinshead KE, Ludwig C, Menara M, Morin A, Castro-Vega LJ et al (2015) Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism. Nat Commun 6:8784
MacKinnon N, Khan AP, Chinnaiyan AM, Rajendiran TM, Ramamoorthy A (2012) Androgen receptor activation results in metabolite signatures of an aggressive prostate cancer phenotype: an NMR-based metabolomics study. Metabolomics 8(6):1026–1036
Marassi RM, Ramamoorthy A, Opella SJ (1997) Complete resolution of the solid-state NMR spectrum of a uniformly 15N-labeled membrane protein in phospholipid bilayers. Proc Natl Acad Sci USA 94:8551–8556
Martinez-Zapien D, Ruiz FX, Poirson J, Mitschler A, Ramirez J, Forster A et al (2016) Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature 529(7587):541–545
Mathe EA, Patterson AD, Haznadar M, Manna SK, Krausz KW, Bowman ED et al (2014) Non-invasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer. Cancer Res 74(12):3259–3270
Mau T, Baleja JD, Wagner GW (1992) Effects of DNA binding and metal substitution on the dynamics of the GAL4 DNA-binding domain as studied by amide proton exchange. Protein Sci 1(11):1403–1412
Mayers JR, Wu C, Clish CB, Kraft P, Torrence ME, Fiske BP et al (2014) Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med 20(10):1193–1198
Miller J, Agarwal A, Devi LA, Fontanini K, Hamilton JA, Pin JP et al (2009) Insider access: pepducin symposium explores a new approach to GPCR modulation. Ann NY Acad Sci 1180(Suppl 1):E1–E12
Mittermaier AK, Kay LE (2009) Observing biological dynamics at atomic resolution using NMR. Trends Biochem Sci 34(12):601–611
Molenaar RJ, Maciejewski JP, Wilmink JW, van Noorden CJF (2018) Wild-type and mutated IDH1/2 enzymes and therapy responses. Oncogene 37(15):1949–1960
Momcilovic M, Shackelford DB (2018) Imaging cancer metabolism. Biomol Ther (Seoul) 26(1):81–92
Montero J, Letai A (2018) Why do BCL-2 inhibitors work and where should we use them in the clinic? Cell Death Differ 25(1):56–64
Mun JH, Lee H, Yoon D, Kim BS, Kim MB, Kim S (2016) Discrimination of basal cell carcinoma from normal skin tissue using high-resolution magic angle spinning 1H NMR spectroscopy. PLoS One 11(3):e0150328
Nelson SJ, Kurhanewicz J, Vigneron DB, Larson PE, Harzstark AL, Ferrone M et al (2013) Metabolic imaging of patients with prostate cancer using hyperpolarized [1-13C]pyruvate. Sci Transl Med 5(198):198ra08
Nomine Y, Charbonnier S, Miguet L, Potier N, Dorsselaer AV, Atkinson RA et al (2005) (1)H and (15)N resonance assignment, secondary structure and dynamic behaviour of the C-terminal domain of human papillomavirus oncoprotein E6. J Biomol NMR 31(2):129–141
O’Callaghan K, Kuliopulos A, Covic L (2012) Turning receptors on and off with intracellular Pepducins: new insights into G-protein-coupled receptor drug development. J Biol Chem 287(16):12787–12796
Oosterhoff JK, Penninkhof F, Brinkmann AO, Grootegoed JA, Blok LJ (2003) REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells. Oncogene 22(19):2920–2925
Palmer AG 3rd. (2015) Enzyme dynamics from NMR spectroscopy. Acc Chem Res 48(2):457–465
Parker JA, Volmar AY, Pavlopoulos S, Mattos C (2018) K-Ras populates conformational states differently from its isoform H-Ras and oncogenic mutant K-RasG12D. Structure 26(6):810–820. e4
Pattni BS, Jhaveri A, Dutta I, Baleja JD, Degterev A, Torchilin V (2017) Targeting energy metabolism of cancer cells: combined administration of NCL-240 and 2-DG. Int J Pharm 532(1):149–156
Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1):27–47
Petros AM, Dinges J, Augeri DJ, Baumeister SA, Betebenner DA, Bures MG et al (2006) Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis. J Med Chem 49(2):656–663
Petros AM, Huth JR, Oost T, Park CM, Ding H, Wang X et al (2010) Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMR. Bioorg Med Chem Lett 20(22):6587–6591
Plathow C, Weber WA (2008) Tumor cell metabolism imaging. J Nucl Med 49(Suppl 2):43S–63S
Powers JF, Cochran B, Baleja JD, Sikes HD, Zhang X, Lomakin I et al (2018) A unique model for SDH-deficient GIST: an endocrine-related cancer. Endocr Relat Cancer 25(11):943–954
Renault M, Tommassen-van Boxtel R, Bos MP, Post JA, Tommassen J, Baldus M (2012) Cellular solid-state nuclear magnetic resonance spectroscopy. Proc Natl Acad Sci USA 109(13):4863–4868
Rowan S, Jiang S, Korem T, Szymanski J, Chang ML, Szelog J et al (2017) Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci USA 114(22):E4472–E4E81
Schopel M, Potheraveedu VN, Al-Harthy T, Abdel-Jalil R, Heumann R, Stoll R (2017) The small GTPases Ras and Rheb studied by multidimensional NMR spectroscopy: structure and function. Biol Chem 398(5–6):577–588
Sevigny LM, Zhang P, Bohm A, Lazarides K, Perides G, Covic L et al (2011) Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins. Proc Natl Acad Sci USA 108(20):8491–8496
Shima F, Matsumoto S, Yoshikawa Y, Kawamura T, Isa M, Kataoka T (2015) Current status of the development of Ras inhibitors. J Biochem 158(2):91–99
Shuker SB, Hajduk PJ, Meadows RP, Fesik SW (1996) Discovering high-affinity ligands for proteins: SAR by NMR. Science 274:1531–1534
Sidi AO, Babah KO, Brimer N, Nomine Y, Romier C, Kieffer B et al (2011) Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6. Protein Expr Purif 80(1):8–16
Sjobakk TE, Vettukattil R, Gulati M, Gulati S, Lundgren S, Gribbestad IS et al (2013) Metabolic profiles of brain metastases. Int J Mol Sci 14(1):2104–2118
Skinner SP, Goult BT, Fogh RH, Boucher W, Stevens TJ, Laue ED et al (2015) Structure calculation, refinement and validation using CcpNmr analysis. Acta Crystallogr D Biol Crystallogr 71(Pt 1):154–161
Somashekar BS, Kamarajan P, Danciu T, Kapila YL, Chinnaiyan AM, Rajendiran TM et al (2011) Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues. J Proteome Res 10(11):5232–5241
Stretch C, Eastman T, Mandal R, Eisner R, Wishart DS, Mourtzakis M et al (2012) Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach. J Nutr 142(1):14–21
Sugiki T, Furuita K, Fujiwara T, Kojima C (2018) Current NMR techniques for structure-based drug discovery. Molecules 23(1)
Swift S, Leger AJ, Talavera J, Zhang L, Bohm A, Kuliopulos A (2006) Role of the PAR1 receptor 8th helix in signaling: the 7-8-1 receptor activation mechanism. J Biol Chem 281(7):4109–4116
Tchernychev B, Ren Y, Sachdev P, Janz JM, Haggis L, O'Shea A et al (2010) Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells. Proc Natl Acad Sci USA 107(51):22255–22259
Tenori L, Oakman C, Claudino WM, Bernini P, Cappadona S, Nepi S et al (2012) Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: a pilot study. Mol Oncol 6(4):437–444
Tessem MB, Swanson MG, Keshari KR, Albers MJ, Joun D, Tabatabai ZL et al (2008) Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn Reson Med 60(3):510–516
Tetlow AL, Tamanoi F (2013) The Ras superfamily G-proteins. Enzymes 33 Pt A:1–14
Tressel SL, Koukos G, Tchernychev B, Jacques SL, Covic L, Kuliopulos A (2011a) Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models. Methods Mol Biol 683:259–275
Tressel SL, Kaneider NC, Kasuda S, Foley C, Koukos G, Austin K et al (2011b) A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis. EMBO Mol Med 3:1–15
Trivedi V, Boire A, Tchernychev B, Kaneider NC, Leger AJ, O'Callaghan K et al (2009) Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell 137(2):332–343
Tsuji M, Ueda S, Hirayama T, Okuda K, Sakaguchi Y, Isono A et al (2013) FRET-based imaging of transbilayer movement of pepducin in living cells by novel intracellular bioreductively activatable fluorescent probes. Org Biomol Chem 11(18):3030–3037
Vander Heiden MG, DeBerardinis RJ (2017) Understanding the intersections between metabolism and cancer biology. Cell 168(4):657–669
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029–1033
Veeraraghavan S, Mello CC, Androphy EJ, Baleja JD (1999) Structural correlates for enhanced stability in the E2 DNA-binding domain from bovine papillomavirus. Biochemistry 38:16115–16124
Warburg O, Wind F, Negelein E (1927) The metabolism of Tumors in the body. J Gen Physiol 8(6):519–530
Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM (2006) Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 78(13):4430–4442
Wielders SJ, Bennaghmouch A, Reutelingsperger CP, Bevers EM, Lindhout T (2007) Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists. J Thromb Haemost 5(3):571–576
Wilson M, Davies NP, Brundler MA, McConville C, Grundy RG, Peet AC (2009) High resolution magic angle spinning 1H NMR of childhood brain and nervous system tumours. Mol Cancer 8:6
Wishart DS, Sykes BD (1994) The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data. J Biomol NMR 4:171–180
Wishart DS, Mandal R, Stanislaus A, Ramirez-Gaona M (2016) Cancer metabolomics and the human Metabolome database. Metabolites 6(1):10
Wüthrich K (1986) NMR of proteins and nucleic acids. Wiley, New York, 292 p
Wüthrich K (1989) Protein structure determination in solution by nuclear magnetic resonance spectroscopy. Science 243:45–50
Wuthrich K (1990) Protein structure determination in solution by NMR spectroscopy. J Biol Chem 265(36):22059–22062
Yamabhai M, Hoffman NG, Hardison NL, McPherson PS, Castagnoli L, Cesareni G et al (1998) Intersectin, a novel adaptor protein with two Eps15 homology and five Src homology 3 domains. J Biol Chem 273(47):31401–31407
Yamaguchi A, Urano T, Goi T, Feig LA (1997) An Eps homology (EH) domain protein that binds to the Ral-GTPase target, RalBP1. J Biol Chem 272:31230–31234
Yang E, Boire A, Agarwal A, Nguyen N, O’Callaghan K, Tu P et al (2009) Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis. Cancer Res 69(15):6223–6231
Yang QJ, Zhao JR, Hao J, Li B, Huo Y, Han YL et al (2018) Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia. J Cachexia Sarcopenia Muscle 9(1):71–85
Yanshole VV, Snytnikova OA, Kiryutin AS, Yanshole LV, Sagdeev RZ, Tsentalovich YP (2014) Metabolomics of the rat lens: a combined LC-MS and NMR study. Exp Eye Res 125:71–78
Zanier K, Ould M’hame Douldsidi A, Boulade-Ladame C, Rybin V, Chappelle A, Atkinson A et al (2012) Solution structure analysis of the HPV16 E6 Oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53. Structure 20(4):604–617
Zhang P, Gruber A, Kasuda S, Kimmelstiel C, O’Callaghan K, Cox DH et al (2012a) Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin. Circulation 126(1):83–91
Zhang C, Srinivasan Y, Arlow DH, Fung JJ, Palmer D, Zheng Y et al (2012b) High-resolution crystal structure of human protease-activated receptor 1. Nature 492:387–392
Zhang P, Leger AJ, Baleja JD, Rana R, Corlin T, Nguyen N et al (2015) Allosteric activation of a G protein-coupled receptor with cell-penetrating receptor Mimetics. J Biol Chem 290(25):15785–15798
Acknowledgments
Funding for this research has been provided in part by the Michael J. Rainen Family Foundation grant (AAH) and grants from the National Institutes of Health, R01-AI38001 and R01-GM067985 (JB) and P50-HL110789 and R01-HL136485 (AK). Acquisition of the NMR spectrometer was assisted by a NIH instrumentation grant (S10OD020073). The authors would like to thank Dr. Janet M. Cowan, Pathology and Laboratory Medicine, Tufts Medical Center, for her invaluable technical assistance and advice in the growth of BCC cultures. We would also like to thank Tatiana Mendez and Betsey Philip for their assistance with NMR data acquisition.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Baleja, J.D., Corlin, T., Kuliopulos, A., Alt-Holland, A. (2019). Applications of NMR in Cancer Research. In: Bose, K., Chaudhari, P. (eds) Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. Springer, Singapore. https://doi.org/10.1007/978-981-32-9816-3_13
Download citation
DOI: https://doi.org/10.1007/978-981-32-9816-3_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9815-6
Online ISBN: 978-981-32-9816-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)